Sound Income Strategies, LLC Trevena Inc Transaction History

Sound Income Strategies, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 13, 2021	BUY	$1.46 - $2.25 $730 - $1,125	500 New	500 $1,000
Q1 2021 Apr 14, 2021	SELL	$1.77 - $2.93 $885 - $1,465	-500 Closed	0 $0
Q3 2020 Oct 08, 2020	BUY	$1.53 - $3.13 $765 - $1,565	500 New	500 $1,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $691M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Sound Income Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Sound Income Strategies, LLC with notifications on news.